RPLCX
Price
$7.20
Change
+$0.03 (+0.42%)
Updated
Aug 24 closing price
Net Assets
180.58M
SLDAX
Price
$7.38
Change
+$0.04 (+0.54%)
Updated
Aug 24 closing price
Net Assets
2.8B
Interact to see
Advertisement

RPLCX vs SLDAX

RPLCX vs SLDAX Comparison Chart in %
View a ticker or compare two or three
VS
RPLCX vs. SLDAX commentary
Aug 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPLCX is a Hold and SLDAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SLDAX has more cash in the bank: 2.8B vs. RPLCX (181M). RPLCX pays higher dividends than SLDAX: RPLCX (5.66) vs SLDAX (5.38). RPLCX was incepted earlier than SLDAX: RPLCX (13 years) vs SLDAX (14 years). RPLCX (0.45) is less costly to investors than SLDAX (0.37). SLDAX is a more actively managed with annual turnover of: 79.00 vs. RPLCX (30.80). SLDAX has a lower initial minimum investment than RPLCX: SLDAX (100000) vs RPLCX (1000000). RPLCX annual gain was more profitable for investors over the last year : 0.63 vs. SLDAX (-0.86). RPLCX return over 5 years is better than : -17.74 vs. SLDAX (-20.11).
RPLCXSLDAXRPLCX / SLDAX
Total Expense Ratio0.450.15300%
Annual Report Gross Expense Ratio0.450.37122%
Fund Existence13 years14 years-
Gain YTD-2.471-3.39373%
Front LoadN/AN/A-
Min. Initial Investment10000001000001,000%
Min. Initial Investment IRAN/AN/A-
Net Assets181M2.8B6%
Annual Yield % from dividends5.665.38105%
Returns for 1 year0.63-0.86-74%
Returns for 3 years13.279.98133%
Returns for 5 years-17.74-20.1188%
Returns for 10 years1.182.4947%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNY45.69-0.16
-0.35%
Sanofi ADS
MLTX15.37-0.39
-2.47%
MoonLake Immunotherapeutics
LEA122.90-5.64
-4.39%
Lear Corp
GSIW15.70-1.32
-7.76%
Garden Stage Limited
RMAX12.36-1.26
-9.25%
Re/Max Holdings